ACELLA HOLDINGS, LLC – Trademark Portfolio
Entity Type: 16
ACELLA HOLDINGS, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include O, OSMODEX, OSMOTICA, OSMOTICA PHARMACEUTICAL, and O OSMOTICA PHARMACEUTICAL. The owner is based in ALPHARETTA, GA.
1880 MCFARLAND PARKWAY, SUITE 110
ALPHARETTA, GA 30005
Showing of trademarks Trademarks
Trademark Classifications
ACELLA HOLDINGS, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ACELLA HOLDINGS, LLC have?
ACELLA HOLDINGS, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 cancelled.
What trademark classes does ACELLA HOLDINGS, LLC file in?
ACELLA HOLDINGS, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ACELLA HOLDINGS, LLC's most well-known trademarks?
ACELLA HOLDINGS, LLC's registered trademark portfolio includes well-known marks such as O, OSMODEX, OSMOTICA, OSMOTICA PHARMACEUTICAL, and O OSMOTICA PHARMACEUTICAL. These are among 5 currently registered trademarks in the portfolio.
What is ACELLA HOLDINGS, LLC's trademark registration success rate?
ACELLA HOLDINGS, LLC has a 63% trademark registration rate, with 5 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.